(Q47348612)
Statements
Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction (English)
Marcus Lind
Ole Torffvit
scientific article published on 19 October 2011